Author

A. V. Suvorova

Observed institution: Canadian Public Health Association

OpenAlex ID: A5111292452

Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC "Pharmcenter VILAR", Russia)

2022 · O. A. Archakova, N. S. Bagaeva, et al. · Drug development & registration · 10

Development and Validation of a Method for Determining Deferasirox in Human Blood Plasma by HPLC-UV

2022 · P. A. Karpova, T. N. Komarov, et al. · Drug development & registration · 2

Application of in vitro studies to predict the pharmacokinetics of rivaroxaban tablets

2024 · A. V. Suvorova, P. A. Losenkova, et al. · Drug development & registration · 1

PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox

2024 · A. V. Suvorova, P. A. Losenkova, et al. · Drug development & registration

Approaches to conducting a physiologically relevant test (PRT) in the study of medicines containing substance IIc of the BCS subclass using sorafenib as an example

2024 · A. V. Suvorova, Yu. V. Medvedev, et al. · Drug development & registration

Performing a physiologically relevant test for cladribine tablets

2024 · P. A. Losenkova, D. D. Gvozdev, et al. · Drug development & registration

Works count: 6

Citation count: 13

H-index: 2

I10-index: 1